Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes ☒ No ☐

As of ~~November 14, 2019,~~October 30, 2020, there were 7,064,603 shares of Class B common stock and ~~28,858,413~~21,671,771 shares of Class A common stock of the registrant issued and outstanding.

	September 30, 2019		December 31, 2018			September 30, 2020		December 31, 2019
	(Unaudited)					(Unaudited)
Assets
Current assets
Cash	$	167,985	$	560,027		$	270,646	$	14,304
Other assets		18,750		—			19,250		—
Total current assets		186,735		560,027			289,896		14,304
Cash and investments held in Trust Account		290,566,451		277,973,009			218,717,961		291,761,159
Total assets	$	290,753,186	$	278,533,036		$	219,007,857	$	291,775,463

Liabilities and Stockholders’ Equity
Sponsor loan – promissory note	$	2,825,841	$	2,750,000
Sponsor loan – promissory notes						$	6,065,665	$	2,825,841
Payables to related party		50,506		100,000			128,246		37,030
Accrued liabilities		997,317		28,169			227,389		1,389,962
Total liabilities		3,873,664		2,878,169			6,421,300		4,252,833
Common stock subject to possible redemption, 27,908,863 and 26,797,511 shares, as of September 30, 2019 and December 31, 2018, respectively, actual and adjusted, at redemption value of $10.10		281,879,516		270,654,861
Common stock subject to possible redemption, 20,371,594 and 27,972,537 shares, as of September 30, 2020 and December 31, 2019, respectively, at redemption value of $10.19 and $10.10, respectively							207,586,553		282,522,624
Stockholders’ equity
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding as of September 30, 2019 and December 31, 2018	—		—
Common stock, Class A $0.0001 par value; 100,000,000 shares authorized; 949,550 and 1,302,489 shares issued and outstanding (excluding 27,908,863 and 26,797,511 shares subject to possible redemption) as of September 30, 2019 and December 31, 2018, respectively		95		130
Common stock, Class B $0.0001 par value; 10,000,000 shares authorized; 7,064,603 and 7,187,500 shares issued and outstanding as of September 30, 2019 and December 31, 2018, respectively		707		719	⁽¹⁾
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; NaN issued or outstanding as of September 30, 2020 and December 31, 2019						—		—
Common stock, Class A $0.0001 par value; 100,000,000 shares authorized; 1,300,177 and 885,876 shares issued and outstanding (excluding 20,371,594 and 27,972,537 shares subject to possible redemption) as of September 30, 2020 and December 31, 2019, respectively							130		88
Common stock, Class B $0.0001 par value; 10,000,000 shares authorized; 7,064,603 shares issued and outstanding as of September 30, 2020 and December 31, 2019							707		707
Additional paid-in-capital		1,168,330		4,808,810			919,653		525,231
Retained earnings		3,830,874		190,347			4,079,514		4,473,980
Total stockholders’ equity		5,000,006		5,000,006			5,000,004		5,000,006

Total liabilities and stockholders’ equity	$	290,753,186	$	278,533,036		$	219,007,857	$	291,775,463

	Three Months Ended September 30,							Nine Months Ended September 30,								Three Months Ended September 30,							Nine Months Ended September 30,
	2019				2018			2019				2018				2020			2019				2020			2019

Revenue	$	—			$	—		$	—			$	—			$	—		$	—			$	—		$	—

Expense
Other expenses		109,776				—			325,208				385				378,512			109,776				1,035,930			325,208
Loss from operations		(109,776	)			—			(325,208	)			(385	)			(378,512	)		(109,776	)			(1,035,930	)		(325,208	)
Other income – Interest income on Trust Account		1,608,191				—			4,933,471				—				7,243			1,608,191				715,458			4,933,471
Income (loss) before provision for income taxes		1,498,415				—			4,608,263				(385	)
(Loss) income before (benefit) provision for income taxes																	(371,269	)		1,498,415				(320,472	)		4,608,263
Income tax (benefit)/provision for income taxes		(143,494	)			—			967,736				—				(11,339	)		(143,494	)			73,994			967,736
Net income (loss) attributable to common stock	$	1,641,909			$	—		$	3,640,527			$	(385	)
Net (loss) income attributable to common stock																$	(359,930	)	$	1,641,909			$	(394,466	)	$	3,640,527

Weighted average number of common stock outstanding:
Class A - Public shares		28,258,413				—			28,180,341				—				26,518,114			28,258,413				27,641,577			28,180,341
Class A - Private placement		600,000				—			600,000				—				600,000			600,000				600,000			600,000
Class B - Common stock		7,064,603		⁽²⁾		6,250,000	⁽¹⁾		7,045,085		⁽²⁾		6,250,000		⁽¹⁾		7,064,603			7,064,603		⁽¹⁾		7,064,603			7,045,085		⁽¹⁾
Basic and diluted net income (loss) per share:
Class A - Public shares	$	0.06			$	—		$	0.14			$	—			$	0.00		$	0.06			$	0.02		$	0.14
Class A - Private placement	$	(0.01	)		$	—		$	(0.04	)		$	—			$	(0.04	)	$	(0.01	)		$	(0.12	)	$	(0.04	)
Class B - Common stock	$	(0.01	)		$	—		$	(0.04	)		$	—			$	(0.04	)	$	(0.01	)		$	(0.12	)	$	(0.04	)

																							Common Stock
																							Class A						Class B							Additional Paid-In-Capital			Retained Earnings (Deficit)			Total Stockholders’ Equity
																							Shares			Amount			Shares			Amount
Balances, June 30, 2020																								1,140,900		$	114			7,064,603		$	707			$	559,737		$	4,439,444		$	5,000,002
Shares subject to possible redemption																								159,277			16		—			—					359,916		—				359,932
Net loss																							—			—			—			—				—				(359,930	)		(359,930	)
Balances, September 30, 2020																								1,300,177		$	130			7,064,603		$	707			$	919,653		$	4,079,514		$	5,000,004

	Common Stock																						Common Stock
	Class A						Class B							Additional Paid-In-Capital			Retained Earnings (Deficit)			Total Stockholders’ Equity			Class A						Class B							Additional Paid-In-Capital			Retained Earnings (Deficit)			Total Stockholders’ Equity
	Shares			Amount			Shares			Amount													Shares			Amount			Shares			Amount
Balances, June 30, 2019		1,112,115		$	111			7,064,603		$	707			$	2,810,220		$	2,188,965		$	5,000,003			1,112,115		$	111			7,064,603		$	707			$	2,810,220		$	2,188,965		$	5,000,003
Shares subject to possible redemption		(162,565	)		(16	)	—			—					(1,641,890	)	—				(1,641,906	)		(162,565	)		(16	)	—			—					(1,641,890	)	—				(1,641,906	)
Net income	—			—			—			—				—				1,641,909			1,641,909		—			—			—			—				—				1,641,909			1,641,909
Balances, September 30, 2019		949,550		$	95			7,064,603		$	707			$	1,168,330		$	3,830,874		$	5,000,006			949,550		$	95			7,064,603		$	707			$	1,168,330		$	3,830,874		$	5,000,006

	Common Stock																						Common Stock
	Class A						Class B							Additional Paid-In-Capital			Retained Earnings (Deficit)			Total Stockholders’ Equity			Class A						Class B							Additional Paid-In-Capital			Retained Earnings (Deficit)			Total Stockholders’ Equity
	Shares			Amount			Shares			Amount													Shares			Amount			Shares			Amount
Balances, June 30, 2018	—			$	—			7,187,500		$	719			$	49,664		$	(7,286	)	$	43,098
Balances, January 1, 2020																								885,876		$	88			7,064,603		$	707			$	525,231		$	4,473,980		$	5,000,006
Shares subject to possible redemption																								414,301			42		—			—					394,422		—				394,464
Net loss	—			—			—			—				—			—			—			—			—			—			—				—				(394,466	)		(394,466	)
Balances, September 30, 2018	—			$	—			7,187,500		$	719			$	49,664		$	(7,286	)	$	43,098
Balances, September 30, 2020																								1,300,177		$	130			7,064,603		$	707			$	919,653		$	4,079,514		$	5,000,004

	Common Stock																						Common Stock
	Class A						Class B							Additional Paid-In-Capital			Retained Earnings (Deficit)			Total Stockholders’ Equity			Class A						Class B							Additional Paid-In-Capital			Retained Earnings (Deficit)			Total Stockholders’ Equity
	Shares			Amount			Shares			Amount													Shares			Amount			Shares			Amount
Balances, January 1, 2019		1,302,489		$	130			7,187,500		$	719			$	4,808,810		$	190,347			5,000,006			1,302,489		$	130			7,187,500		$	719		⁽²⁾	$	4,808,810		$	190,347		$	5,000,006
Sale of Class A common stock to the public		758,413			76		—			—					7,584,054		—				7,584,130			758,413			76		—			—					7,584,054		—				7,584,130
Forfeiture of common stock to sponsor at $0.0001 par value	—			—				(122,897	)		(12	)	⁽²⁾		12		—				—		—			—				(122,897	)		(12	)	⁽¹⁾		12		—			—
Shares subject to possible redemption		(1,111,352	)		(111	)	—			—					(11,224,546	)	—				(11,224,657	)		(1,111,352	)		(111	)	—			—					(11,224,546	)	—				(11,224,657	)
Net income	—			—			—			—				—				3,640,527			3,640,527		—			—			—			—				—				3,640,527			3,640,527
Balances, September 30, 2019		949,550		$	95			7,064,603		$	707			$	1,168,330		$	3,830,874		$	5,000,006			949,550		$	95			7,064,603		$	707			$	1,168,330		$	3,830,874		$	5,000,006

	Common Stock
	Class A						Class B							Additional Paid-In-Capital			Retained Earnings (Deficit)			Total Stockholders’ Equity
	Shares			Amount			Shares			Amount
Balances, January 1, 2018	—			$	—			7,187,500		$	719		⁽¹⁾	$	49,664		$	(6,900	)	$	43,483
Net loss	—			—			—			—				—				(385	)		(385	)
Balances, September 30, 2018	—			$	—			7,187,500		$	719			$	49,664		$	(7,286	)	$	43,098

	Nine Months Ended September 30,						Nine Months Ended September 30,
	2019			2018			2020			2019
Cash flows from operating activities
Net income/(loss)	$	3,640,527		$	(385	)
Adjustments to reconcile net income/(loss) to net cash used in operating activities
Interest earned on held to maturity securities held in Trust Account		(4,933,471	)		—
(Increase) decrease in operating assets
Net (loss) income							$	(394,466	)	$	3,640,527
Adjustments to reconcile net (loss) income to net cash used in operating activities
Interest earned on investments held in Trust Account								(715,458	)		(4,933,471	)
Deferred tax benefit								—			—
Increase in operating assets
Other assets		(18,750	)		—			(19,250	)		(18,750	)
Deferred offering costs	—				(43,624	)
Increase (decrease) in operating liabilities
Payable to related party		50,506			44,009			91,216			50,506
Accrued liabilities		969,148			—			(1,162,574	)		969,148
Net cash used in operating activities		(292,040	)		—			(2,200,532	)		(292,040	)

Cash flows from investing activities
Proceeds deposited in Trust Account		(7,659,971	)		—			(2,489,824	)		(7,659,971	)
Net cash used in investing activities		(7,659,971	)		—
Proceeds from Trust Account to pay tax								1,706,874			—
Proceeds from Trust Account								74,541,606			—
Net cash provided by (used in) investing activities								73,758,656			(7,659,971	)

Cash flows from financing activities
Redemption of units disbursement								(74,541,606	)		—
Proceeds from sale of units in the initial public offering, net of underwriting discount and offering cost paid		7,584,128			—			—			7,584,128
Proceeds from related party promissory notes		75,841			—			750,000			—
Proceeds from related party - Sponsor loan								2,489,824			75,841
Payment of related party payable		(100,000	)		—			—			(100,000	)
Net cash provided by financing activities		7,559,969			—
Net cash provided by (used in) financing activities								(71,301,782	)		7,559,969

Net decrease in cash		(392,042	)		—
Net increase (decrease) in cash								256,342			(392,042	)
Cash at beginning of period		560,027			45,890			14,304			560,027
Cash at end of period	$	167,985		$	45,890		$	270,646		$	167,985

Supplemental disclosure of cash flow activities
Cash paid for income tax							$	1,226,992		$	—

Supplemental disclosure of non-cash financing activities
Accrued offering costs included in deferred offering costs	$	—		$	15,001
Change in common stock subject to possible redemption	$	11,224,655		$	—		$	(394,465	)	$	11,224,655

Description of Business - CF Finance Acquisition Corp. (the “Company”) was incorporated in Delaware on July 9, 2014. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”).

Although the Company is not limited to a particular industry or sector for the purpose of consummating a Business Combination, the Company intends to focus its search on companies operating in the financial services or real estate industries. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

As of September 30, ~~2019,~~2020, the Company had not yet commenced operations. All activity for the three and nine months ended September 30, ~~2019~~2020 and ~~2018~~2019 relates to the Company’s ~~formation and Public Offering described below and, subsequent to the Public Offering,~~ efforts ~~have been directed~~ toward locating and completing a suitable Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company has generated non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the Public Offering. The Company has selected December 31^st as its fiscal year end.

The Company’s Sponsor is CF Finance Holdings, LLC (the “Sponsor”). The registration statement for the Public Offering (see Note 3) was declared effective by the United States Securities and Exchange Commission (the “SEC”) on December 12, 2018. The Company intends to finance a Business Combination with the proceeds of approximately $282,600,000 (approximately $208,100,000, as adjusted for the redemption described below) from the Public Offering, $6,000,000 from the Private Placement (see Note 4) and approximately $2,826,000 (approximately $5,315,700, as adjusted for the redemption described below) from the Sponsor loan (see Note 4). Offering costs for the Public Offering amounted to approximately $5,585,900, consisting of $5,100,000 of underwriting fees and approximately $485,900 of other costs.

On June 15, 2020, the stockholders of the Company approved the extension of the termination of the Company from June 17, 2020 to September 17, 2020. In conjunction with the termination date extension vote, public stockholders exercised their right to elect to redeem 593,700 shares of Common Stock. $6,096,437 was withdrawn from the Trust Account in connection with the redemption of such shares. On September 16, 2020, an additional $12,406 was withdrawn from the Trust Account in connection with the redemption of such shares. In addition, in conjunction with the termination date extension, the Sponsor committed to contribute an additional $0.09 per remaining Public Share to the Trust Account in the form of a Sponsor Loan. On June 17, 2020, an additional $2,489,824 was contributed to the Trust Account.

On September 10, 2020, the stockholders of the Company approved the extension of the termination of the Company from September 17, 2020 to December 17, 2020. In conjunction with the termination date extension vote, public stockholders exercised their right to elect to redeem 6,592,942 shares of Common Stock. $68,432,763 was withdrawn from the Trust Account in connection with the redemption of such shares.

Initial Business Combination - The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Public Offering and the sale of Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the assets held in the Trust Account (as defined below) (excluding taxes payable on income earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). Upon the closing of the Public Offering and the underwriter’s partial exercises of the over-allotment option, an amount equal to $10.10 per Unit sold in the Public Offering, including the proceeds of the Private Placement Units and Sponsor Loan (see Note 4), was held in a Trust Account, with Continental Stock Transfer & Trust Company acting as trustee. The proceeds are invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 180 days or less or in any open-ended Investment Company that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.

The Company will provide its holders of the outstanding shares of its Class A common stock, par value $0.0001 (“Class A common stock”), sold in the Public Offering (the “public stockholders”) with the opportunity to redeem all or a portion of their public shares (the “Public Shares”) upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their Public Shares (see Note 3) for a pro rata portion of the amount then in the Trust Account (initially $10.10 per Public Share).These Public Shares will be recorded at a redemption value and classified as temporary equity upon the completion of the Public Offering in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from ~~Equity”.~~ Equity. In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation ~~(the~~(as amended from time to time, the “Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the SEC and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law or rules of the stock exchange, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks stockholder approval in connection with a Business Combination, the Company’s Sponsor (the “initial stockholders”), officers and directors have agreed to vote their Founder Shares (see Note 4) and any Public Shares purchased during or after the Public Offering in favor of a Business Combination. In addition, the initial stockholders, officers and directors have agreed to waive their redemption rights with respect to their Founder Shares and shares included in the Private Placement Units held by the initial stockholders, officers and directors in connection with the completion of a Business Combination.

Notwithstanding the foregoing, the Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), will be restricted from redeeming its shares with respect to more than an aggregate of 20% or more of the Class A common stock sold in the Public Offering, without the prior consent of the Company.

The initial stockholders, officers and directors have agreed not to propose an amendment to the Amended and Restated Certificate of Incorporation (i) that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination or (ii) with respect to any other provision relating to stockholders’ rights or pre-business combination activity, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.

On August 2, 2020, the Company entered into a Transaction Agreement (the “Transaction Agreement”) with CF Finance Intermediate Acquisition, LLC, a Delaware limited liability company and direct wholly owned subsidiary of the Company, Sponsor, Grosvenor Holdings, LLC, an Illinois limited liability company, Grosvenor Capital Management Holdings, LLLP, an Illinois limited liability limited partnership (“Grosvenor Capital”), GCM Grosvenor Management, LLC, a Delaware limited liability company, Grosvenor Holdings II, L.L.C., a Delaware limited liability company, GCMH GP, L.L.C., a Delaware limited liability company, GCM V, LLC, a Delaware limited liability company, and GCM Grosvenor Inc., a Delaware corporation and a direct wholly owned subsidiary of Grosvenor Capital (“GCM PubCo”). Pursuant to the Transaction Agreement, the Company will be merged (the “Merger”) with and into GCM PubCo, with GCM PubCo surviving the Merger, as a result of which GCM PubCo, as the surviving corporation in the Merger, will indirectly hold approximately 26.1% of the outstanding equity interests of Grosvenor Capital, assuming that no shares of the Company are redeemed in connection with the Merger. The shares of Class A common stock will automatically convert into shares of GCM Pubco Class A common stock in connection with the Merger.For more information about the business combination, see the definitive proxy statement/prospectus dated October 14, 2020 and filed with the SEC on October 15, 2020.

In connection with the execution of the Transaction Agreement, on August 2, 2020, the Company entered into Subscription Agreements with certain investors (the “PIPE Investors”) pursuant to which, immediately following the consummation of the Merger, such PIPE Investors will purchase an aggregate of 19,500,000 shares of GCM PubCo Class A common stock at $10.00 per share for an aggregate purchase price of $195,000,000 (the “PIPE Transaction”).

Forward Purchase Contract - ~~The~~– In connection with the Public Offering, the Sponsor ~~has~~ committed, pursuant to a forward purchase contract with the Company, to purchase, in a Private Placement for gross proceeds of $30,000,000 to occur concurrently with the consummation of an initial Business Combination, 3,000,000 of the Company’s Units on substantially the same terms as the sale of Units in the initial Public Offering at $10.00 per Unit, and 750,000 shares of Class A common stock. In connection with the execution of the Transaction Agreement regarding its initial Business Combination, on August 2, 2020, the Company and the Sponsor entered into Amendment No. 1 to Forward Purchase Contract, pursuant to which, among other things, the Sponsor agreed to purchase, subject to the Company’s consummation of a Business Combination with GCM PubCo and its affiliates, to a reduction in the total equity issuable under such contract to a total of 3,500,000 shares of GCM PubCo Class A common stock and 1,500,000 GCM PubCo common warrants, for the same $30,000,000 in gross proceeds. The funds from the sale of ~~Units~~Company’s securities in the forward purchase contract, as amended, will be used as part of the consideration to the sellers in the initial Business Combination; any excess funds from this Private Placement will be used for working capital in the post-transaction company. This commitment is independent of the percentage of stockholders electing to redeem their Public Shares and provides the Company with a minimum funding level for the initial business combination.

Failure to Consummate a Business Combination - If the Company is unable to complete a Business Combination ~~within 18 months from the closing~~by December 17, 2020 (which was originally June 17, 2020, but has been extended by two stockholder approvals) (or if such date is extended at a duly called meeting of ~~the Public Offering~~our stockholders, such later date) (the “Combination Period”), ~~which is by June 17, 2020,~~ the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay franchise and income taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. The Combination Period extension from June 17, 2020 to September 17, 2020 was approved by stockholders at the stockholders’ meeting on June 15, 2020, and the Combination Period extension from September 17, 2020 to December 17, 2020 was approved by stockholders at the stockholders’ meeting on September 10, 2020.

The initial stockholders, officers and directors have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the initial stockholders, officers and directors acquire Public Shares in or after the Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.10 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriter of the Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, except for the Company’s independent registered public accounting firm, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

The Trust Account - The proceeds in the Trust Account will be invested only in U.S. government treasury bills with a maturity of one hundred and eighty (180) days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act of 1940 which invest only in direct U.S. government obligations. Funds will remain in the Trust Account until the earlier of (i) the consummation of the Company’s initial Business Combination or (ii) the distribution of the Trust Account proceeds as described below. The remaining proceeds outside the Trust Account may be used to pay for business, legal and accounting due diligence expenses for prospective acquisition targets and continuing general and administrative expenses. As of September 30, 2020 and December 31, 2019, investment securities in the Trust Account consisted of ~~$290,304,935~~$218,717,961 and $291,761,159 in ~~U.S. government treasury bills and $261,516 in a~~ money market ~~fund. As of December 31, 2018, investment securities in the Trust Account consisted of $252,721,203 in U.S. government treasury bills and $25,251,806 held as cash.~~funds. The Amended and Restated Certificate of Incorporation provides that, other than the withdrawal of interest to pay taxes, if any, none of the funds held in the Trust Account will be released until the earlier of: (i) the completion of the Business Combination; or (ii) the redemption of 100% of the Public Shares included in the Units being sold in the Public Offering if the Company is unable to complete a Business Combination by ~~June 17, 2020 (subject~~the Combination Period, subject to the requirements of ~~law).~~law.

During three and nine months ended September 30, 2020, $1,268,146 and $1,605,028 of the proceeds from the Trust Account were used to pay taxes, respectively.

Basis of presentation - The unaudited condensed financial statements are presented in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the SEC and reflect all adjustments, consisting only of normal recurring adjustments, which are, in the opinion of management, necessary for a fair presentation of the financial position as of September 30, ~~2019~~2020 and the results of operations and cash flows for the periods presented. Certain information and disclosures normally included in financial statements prepared in accordance with US GAAP have been omitted pursuant to such rules and regulations. Interim results are not necessarily indicative of results for a full year. The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Form 10-K filed by the Company with the SEC on March ~~29, 2019.~~6, 2020.

In connection with the Company’s going concern considerations in accordance with ASU 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern” as of September 30, ~~2019,~~2020, the Company may not have sufficient liquidity to meet its current obligations over the next year from issuance of the unaudited condensed financial statements. However, management has determined that the Company has access to funds from the Sponsor, the Sponsor has committed, in the form of a loan, up to $750,000 to be provided to the Company (see Note 4), and the Sponsor, along with an affiliate of the Sponsor, has financial wherewithal to provide such funds, including an aggregate of $1,500,000 intended to be provided under a related party loan (the “Related Party Loan”) (see Note 4) that are sufficient to fund the working capital needs until the earlier of the consummation of a Business Combination or the end of the Combination Period. The Company’s original mandatory liquidation date of June 17, 2020 was extended to September 17, 2020 through a stockholder vote on June 15, 2020. The Company’s mandatory liquidation date of ~~June~~September 17, 2020 was extended further to December 17, 2020 through a stockholder vote on September 10, 2020. On August 2, 2020, the Company entered into the Transaction Agreement. The consummation of the Business Combination pursuant to the Transaction Agreement is subject to, among other closing conditions, the approval of the stockholders of the Company, and other terms and conditions as described in Form 8-K, filed with the SEC on August 3, 2020, Form 8-K/A, filed with the SEC on August 4, 2020, and the definitive proxy statement/prospectus dated October 14, 2020 and filed with the SEC on October 15, 2020. The Company’s mandatory liquidation date raises substantial doubt about ~~its~~the entity’s ability to continue as a going concern. These unaudited condensed financial statements do not include any adjustments related to the recovery of the recorded assets or the classification of the liabilities should the Company be unable to continue as a going concern. As discussed in Note 1, in the event of a mandatory liquidation, within ten business days, the Company will redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay franchise and income taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares.

Emerging growth company - The Company is an “emerging growth company”, as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited condensed financial statements with another public company, which is neither an emerging growth company nor an emerging growth company, which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates - The preparation of unaudited condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

Cash and investments held in Trust Account - As of September 30, ~~2019~~2020 and December 31, ~~2018,~~2019, the assets held in the Trust Account were held in ~~cash,~~ money market ~~fund, and U.S. government treasury bills.~~

~~Deferred Offering Costs -~~ Deferred offering costs consist of legal and accounting fees incurred through the balance sheet dates that are directly related to the Public Offering and that were charged to stockholders’ equity upon the completion of the Public Offering.funds.

Income Taxes ~~- The Company accounts~~– Income taxes are accounted for ~~income taxes~~under ASC Topic 740, Income Taxes, using the asset and liability ~~method as prescribed in ASC Topic 740,~~ ~~Income Taxes~~.method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the ~~unaudited condensed~~ financial ~~statement~~statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that ~~includes~~included the enactment date. To the extent that it is more likely than not that deferred tax assets will not be recognized, a valuation allowance would be established to offset their benefit. As of September 30, 2020 and December 31, 2019, the Company had no material deferred tax assets or liabilities.

ASC Topic 740 prescribes a recognition threshold that a tax position is required to meet before being recognized in the unaudited condensed financial statements. The Company provides for uncertain tax positions based upon management’s assessment of whether a tax benefit is more likely than not to be sustained upon examination by tax authorities. The Company recognizes interest and penalties related to unrecognized tax benefits as provision for income taxes on the unaudited condensed statements of operations. There were no0 unrecognized tax benefits and no0 amounts accrued for interest and penalties as of September 30, ~~2019~~2020 and December 31, ~~2018.~~2019.

The Company may be subject to examination by federal, state and city taxing authorities in the areas of income taxes. The Company is currently not under examination by tax authorities and is not aware of any issues that may result in significant payments or accruals. Accordingly, the Company does not believe that the amounts of unrecognized tax benefits will materially change over the next twelve months.

Net Income (Loss) per Common Share - The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per ~~Share”~~Share. Net income (loss) per common share is computed by dividing net income (loss) applicable to common stockholders by the weighted average number of common shares outstanding for the period, after deducting shares that are subject to forfeiture in connection with the Public Offering.

As of September 30, ~~2019,~~2020, the Company has not considered the effect of the warrants sold in the Public Offering and Private Placement to purchase an aggregate of 21,643,809 shares of Class A common stock in the calculation of diluted earnings per share, since their inclusion would be anti-dilutive under the treasury stock method. As of September 30, 2019, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into shares of common stock and then share in the earnings of the Company. As a result, diluted income (loss) per share is the same as basic income (loss) per share for the periods presented.

Net income per share, for Class A – public shares common stock is calculated by dividing the interest income earned on the Trust Account of approximately $7,000 and $715,000 for the three and nine months ended September 30, 2020, and $1,608,000 and $4,933,000 for the three and nine months ended September 30, 2019, respectively, less interest to pay taxes permitted to be withdrawn from the Trust Account by the weighted average number of Class A – public shares common stock outstanding for the period. Net income per share, Class A excludes the shares sold in the private placement because those shares do not have the same redemption rights as the Class A shares sold in the Public Offering. Net income (loss) per share, Class A – private placement and Class B common stock is calculated by dividing the net income, excluding interest income earned on the Trust Account and interest to pay taxes permitted to be withdrawn from the Trust Account, by the weighted average number of Class A – private placement and Class B common stock outstanding for the period.

Concentration of Credit Risk - Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal depository insurance coverage of $250,000. As of September 30, ~~2019~~2020 and December 31, ~~2018,~~2019, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.

Financial Instruments - The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC Topic 820, “Fair Value Measurements and ~~Disclosures”~~Disclosures, approximates the carrying amounts represented in the accompanying balance sheets, primarily due to their short-term nature.

Recently Issued Accounting Pronouncements - The Company’s management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

The Company closed the Public Offering for the sale of approximately 28,260,000 (approximately 21,100,000 after the redemptions on June 15, 2020 and September 10, 2020) Units at a price of $10.00 per Unit, yielding gross proceeds of approximately ~~$282,600,000.~~$282,600,000 (approximately $208,100,000, as adjusted for redemptions on June 15, 2020 and September 10, 2020). In December 2018, the Company closed the Public Offering for the sale of 27,500,000 Units at a price of $10.00 per Unit, yielding proceeds of $275,000,000. The closings occurred on December 17, 2018 with respect to 25,000,000 Units and on December 31, 2018 with respect to 2,500,000 Units related to the partial exercise of the underwriter’s over-allotment option. In January 2019, the underwriter exercised the over-allotment option of 758,413 additional Units at $10.00 per Unit, yielding proceeds of $7,584,130. On June 15, 2020 and September 10, 2020, public shareholders exercised their right to redeem 593,700 and 6,592,942 Units at a redemption value of $6,108,843 (including the additional redemption value of $12,406 due to the change in estimated income tax), and $68,432,763, respectively.

Each Unit consists of one share of Class A common stock, and three-quarters of one redeemable warrant (each, a “Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 7).

Simultaneous with the closing of the Public Offering on December 17, 2018, the Sponsor purchased an aggregate of 600,000 Private Placement Units at a price of $10.00 per Unit ($6,000,000 in the aggregate) in a private placement. Each Unit consists of one share of Class A common stock and three-quarters of one warrant. Each whole warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 7). The Private Placement Units are not redeemable from funds deposited in the Trust Account.

Upon the December 2018 and January 2019 closings of the Public Offering, and June 2020 termination extension vote (see Note 1), the Sponsor funded loans in the amount of $2,750,000, $75,841 and ~~$75,841,~~$2,489,824, respectively, pursuant to a promissory note issued by the Company. The promissory note is at nominal or no interest (see Note 4).

Upon the closing of the Public Offering and the sale of the Private Placement Units, and taking into consideration the offering costs, an aggregate of approximately $286,000,000 (approximately $211,500,000 after the redemptions on June 15, 2020 and September 10, 2020) was deposited in the Trust Account.

In July 2014, the Sponsor purchased 2,875,000 Founder Shares of the Company’s Class B common stock, par value $0.0001 (“Class B common stock”) for an aggregate price of $383. During 2015, the Sponsor contributed an additional $50,000 to the Company’s paid-in capital for no additional shares. The Founder Shares will automatically convert into shares of Class A common stock at the time of the Company’s initial Business Combination and are subject to certain transfer restrictions (see Note 7).

Holders of Founder Shares may also elect to convert their shares of Class B common stock into an equal number of shares of Class A common stock, subject to adjustment, at any time. In January 2019, 122,897 shares were forfeited by the Sponsor so that the Founder Shares represent 20% of the Company’s issued and outstanding shares after the Public Offering (not including the placement shares).

The initial stockholders, officers and directors have agreed, subject to limited exceptions, not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A) one year after the completion of the initial Business Combination or (B) subsequent to the initial Business Combination, (x) if the last reported sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20-trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property.

Upon the December 17, 2018 closing of the Public Offering, the Sponsor paid the Company $6,000,000 for the purchase of the 600,000 Private Placement Units at a price of $10.00 per Private Placement Unit. Each Unit consists of one share of Class A common stock and three-quarters of one warrant. Each whole warrant sold as part of each Private Placement Unit is exercisable for one share of Class A common stock at a price of $11.50 per share. The proceeds from the Private Placement Units were added to the proceeds from the Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Units held in the trust account will be used to fund the redemption of the Company’s Public Shares (subject to the requirements of applicable law). The warrants included in the Private Placement Units will be non-redeemable and exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees. The warrants will expire five years after the completion of the Company’s Business Combination or earlier upon redemption or liquidation.

The Sponsor and the Company’s officers and directors have agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Units until 30 days after the completion of the initial Business Combination.

In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the warrants included in the Private Placement Units.

In order to finance transaction costs in connection with an intended initial Business Combination, the Sponsor has committed, in the form of a loan, up to $750,000 to be provided to the Company to fund the Company’s expenses relating to investigating and selecting a target business and other working capital requirements prior to the Company’s initial Business Combination. Such loan may be convertible into warrants, at a price of $1.00 per warrant at the option of the Sponsor.

The Sponsor previously made available to the Company, under a promissory note, up to $300,000 to be used for a portion of the expenses of the Public Offering. The promissory note is non-interest bearing. As of September 30, ~~2019 and December 31, 2018,~~2020, the Company had ~~amounts~~$750,000 outstanding under the ~~promissory note~~loan. As of December 31, 2019, the Company didn’t have any outstanding balance under the loan.

The Sponsor pays expenses on the Company’s behalf. The Company reimburses the Sponsor. The unpaid balance is included in Payables to related parties on the accompanying condensed balance sheets. As of September 30, 2020 and as of December 31, 2019, the Company had accounts payable outstanding to Sponsor for such expenses paid on the Company’s behalf of approximately ~~$50,000~~$128,000 and ~~$100,000,~~$37,000, respectively.

Upon the closings of the Public Offering, the Sponsor funded loans in the amount of $2,750,000 in December 2018 and $75,841 in January ~~2019 for~~2019. In June 2020, the Sponsor funded an additional loan in the amount of $2,489,824 in conjunction with the termination date extension vote (see Note 1). The aggregate amount of ~~$2,825,841,~~the loans is $5,315,665, pursuant to a promissory ~~note~~notes issued by the Company. The promissory ~~note is~~notes are interest free. The proceeds of the Sponsor loans were deposited into the Trust Account and will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law). The Sponsor loans shall be repaid or converted into units of the Company, at the Sponsor’s discretion, only upon consummation of the Business Combination. Such units would be identical to the Units sold in the Public Offering except that the Sponsor loan warrants will be non-redeemable and exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees. The Sponsor loan was extended in order to ensure that the amount in the Trust Account was initially $10.10 and $10.19 after the additional loan funding in June 2020, per Public Share. If there is no Business Combination, the Sponsor loan will not be repaid and the loan’s proceeds will be distributed to the public stockholders. The Sponsor has waived any claims against the Trust Account in connection with the Sponsor loan.

The holders of Founder Shares, Private Placement Units (and component securities) and warrants that may be issued upon conversion of Working Capital Loans, if any, will be entitled to registration rights (in the case of the Founder Shares, only after conversion of such shares to shares of Class A common stock). The registration rights agreement was signed on December 12, 2018. These holders are entitled to certain demand and “piggyback” registration rights. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until the termination of the applicable lock-up period for the securities to be registered. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

~~Notes~~In connection with the Business Combination, the registration rights agreement is being amended to ~~Unaudited Condensed Financial Statements (continued)~~

~~5. Commitments (continued)~~provide that GCM Pubco will register for resale certain shares of common stock and other equity securities that are held by the parties thereto from time to time.

Cantor Fitzgerald & Co., the underwriter of the Public Offering and an affiliate of the Sponsor, purchased approximately 3,260,000 additional Units to cover over-allotments, at the Public Offering price less the underwriting discounts and commissions.

The underwriter was entitled to an underwriting discount of $0.20 per Unit, or $5,000,000 in the aggregate, even if the underwriter’s over-allotment was exercised in full. The underwriter has paid approximately $32,600,000 for 3,260,000 Units.

The Company also engaged a qualified independent underwriter to participate in the preparation of the registration statement and exercise the usual standards of “due diligence” in respect thereto. The Company paid the independent underwriter a fee of $100,000 upon the completion of the Public Offering in consideration for its services and expenses as the qualified independent underwriter. The independent underwriter will receive no other compensation. The fee was charged directly to ~~stockholders'~~stockholders’ equity upon completion of the IPO.

Business Combination Marketing Agreement and Additional Fees Payable to Affiliates

The Company has engaged Cantor Fitzgerald & Co. as an advisor in connection with the Company’s initial Business Combination to assist the Company in holding meetings with its stockholders to discuss the potential Business Combination and the target business’ attributes, introduce the Company to potential investors that are interested in purchasing the Company’s securities, assist the Company in obtaining stockholder approval for the Business Combination and assist the Company with its press releases and public filings in connection with the Business Combination. The Company will pay Cantor Fitzgerald & Co. a cash fee for such services upon the consummation of the Business Combination in an amount equal to, in the aggregate, 3.5% of the gross proceeds of the Public Offering, including any proceeds from the partial exercise of the underwriters’ over-allotment option.

~~6. Trust Account~~In addition, upon completion of the Business Combination, and ~~Fair Value Measurements~~assuming no change in the amount of the PIPE Transaction, an aggregate amount of approximately $7.8 million in advisory fees and placement agent fees will be payable to Cantor Fitzgerald & Co., an affiliate of ours and the Sponsor.

As of September 30, 2019 and December 31, 2018, investment securities in the Company’s Trust Account consisted of $290,304,935 and $252,721,203, respectively, in U.S. government treasury bills, and $261,516 held in a money market fund as of September 30, 2019 and $25,251,806 held in cash as of December 31, 2018. The Company classifies its Treasury Instruments as held-to-maturity in accordance with FASB ASC 320 "~~Investments - Debt and Equity Securities~~". Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity securities are recorded at amortized cost on the accompanying September 30, 2019 and December 31, 2018 balance sheets and adjusted for amortization or accretion of premiums or discounts. The following table presents information about the Company's assets that are measured at fair value on a recurring basis as of September 30, 2019 and December 31, 2018 and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value. In addition, the table presents the carrying value under ASC 320, excluding accrued interest income and gross unrealized holding gain. Since all of the Company's permitted investments consist of U.S. government treasury bills, money market fund and cash, fair values of its investments are determined by Level 1 inputs utilizing quoted prices (unadjusted) in active markets for identical assets as follows:

Fair Value – U.S. GAAP defines fair value as the price received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date and requires certain disclosures about such fair value measurements. The Company follows the guidance in ASC 820 for its financial assets that are re-measured and reported at fair value at each reporting period.

The guidance establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

As required by U.S. GAAP guidance, financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

The following tables present information about the Company’s assets that are measured at fair value on a recurring basis as of September 30, 2020 and December 31, 2019, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

Class A Common Stock - The Company is authorized to issue 100,000,000 shares of Class A common stock with a par value of $0.0001 per share. As of September 30, ~~2019~~2020 and December 31, ~~2018,~~2019, there were ~~28,858,413~~21,671,771 and ~~28,100,000~~28,858,413 shares of Class A common stock issued and outstanding including ~~27,908,863~~20,371,594 and ~~26,797,511~~27,972,537 of shares subject to redemption, respectively. Class A Common Stock includes 600,000 shares sold in a Private Placement. The shares sold in the Private Placement do not contain the same redemption feature contained in the shares sold in the Public Offering.

Class B Common Stock - The Company is authorized to issue 10,000,000 shares of Class B common stock with a par value of $0.0001 per share. Holders of Class B common stock are entitled to one vote for each share. As of September 30, ~~2019~~2020 and December 31, ~~2018,~~2019, there were 7,064,603 ~~and 7,187,500~~ shares of Class B common stock outstanding, respectively, of which ~~none and 312,500 shares, respectively,~~NaN were subject to forfeiture to the Company by the Sponsor for no consideration to the extent that the underwriter’s over-allotment option is not exercised in full, so that the initial stockholders, officers and directors will collectively own 20% of the Company’s issued and outstanding common stock after the Public Offering, not including the Private Placement Units. Holders of Class A common stock and Class B common stock will vote together as a single class on all other matters submitted to a vote of stockholders except as required by law. Upon the final exercise of the underwriters' over-allotment option in January 2019, the Sponsor forfeited 122,897 shares of Class B common stock.

The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the initial Business Combination on a one-for-one basis, subject to adjustment. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts sold in the Public Offering and related to the closing of the initial Business Combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the holders of a majority of the outstanding shares of Class B common stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of all shares of common stock outstanding upon the completion of the Public Offering, not including the Private Placement Units, plus all shares of Class A common stock and equity-linked securities issued or deemed issued in connection with the initial Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial Business Combination and any private placement-equivalent warrants issued to the Sponsor or its affiliates upon conversion of loans made to the Company). Holders of Founder Shares may also elect to convert their shares of Class B common stock into an equal number of shares of Class A common stock, subject to adjustment as provided above, at any time.

Preferred stock - The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of September 30, ~~2019~~2020 and December 31, ~~2018,~~2019, there were no0 shares of preferred stock issued or outstanding.

Warrants - Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the shares of common stock issuable upon exercise of the Public Warrants and a current prospectus relating to them is available. The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of a Business Combination, the Company will use its commercially reasonable best efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the shares of Class A common stock issuable upon exercise of the Public Warrants. The Company will use its commercially reasonable best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the Public Warrants in accordance with the provisions of the warrant agreement. Notwithstanding the foregoing, if a registration statement covering the shares of Class A common stock issuable upon exercise of the Public Warrants is not effective within a specified period following the consummation of Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.

The warrants included in the Private Placement Units are identical to the Public Warrants underlying the Units being sold in the Public Offering, except that the warrants included in the Private Placement Units and the Class A common stock issuable upon the exercise of the warrants included in the Private Placement Units are not transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions.

Additionally, the warrants included in the Private Placement Units will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the warrants included in the Private Placement Units are held by someone other than the initial purchasers or their permitted transferees, the warrants included in the Private Placement Units will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. The warrants will expire five years after the completion of the Company’s Business Combination or earlier upon redemption or liquidation.

The Company may redeem the Public Warrants (except with respect to the warrants included in the Private Placement Units):

If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis”, as described in the warrant agreement.

The exercise price and number of shares of Class A common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of Class A common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

On January 17, 2018, the Sponsor effectuated a recapitalization of the Company, which included a 2.5-for-1 stock split resulting in an aggregate of 7,187,500 Founder Shares outstanding and held by the Sponsor (312,500 of which were subject to forfeiture as the underwriter’s over-allotment option was not exercised in full by December 31, 2018. After the underwriter exercised the second over-allotment on January 29, 2019, the shares forfeited were 122,897). Information contained in the unaudited condensed financial statements has been adjusted for this split.

The Company has evaluated subsequent events through the date the unaudited condensed financial statements were issued. There have been no ~~additional~~ material subsequent events that would require recognition in these unaudited condensed financial statements or disclosure in the notes to the unaudited condensed financial ~~statements.~~statements, except as outlined below.

On October 1, 2020, the Company issued a press release announcing that it has established October 8, 2020 as the record date for the special meeting of stockholders to be held with respect to the previously announced business combination with GCM PubCo. (see Note 1). In addition, on October 15, 2020, the Company filed a definitive proxy statement announcing that the stockholders meeting to approve the Transaction Agreement will be held on November 3, 2020.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

We are a blank check company incorporated on July 9, 2014 as a Delaware corporation and formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). We intend to effectuate our Business Combination using cash from the proceeds of our initial public offering ~~on December 17, 2018~~ (the “Public Offering”) ~~and~~, the sale of units in a private placement (the “Private Placement”) that occurred simultaneously with the completion of the Public Offering (the “Private Placement Units”), the proceeds of the sale of our securities in connection with our ~~business combination~~Business Combination (pursuant to the forward purchase contract and any backstop agreements we may enter into following the consummation of this offering or otherwise), and our capital stock, debt or a combination of cash, stock and debt. On December 31, 2018, the underwriter partially exercised 2,500,000 Units of the over-allotment option and on January 29, 2019, the underwriter partially exercised the over-allotment option and purchased an additional 758,413 Units. Since the over-allotment was not exercised in full, simultaneously with the exercise of the second partial exercise of the over-allotment option, our sponsor forfeited 122,897 shares of our Class B common stock. Our sponsorCF Finance Holdings, LLC (the “Sponsor”) has committed, pursuant to a forward purchase contract with us (the “Forward Purchase Contract”), to purchase, in a private placement for gross proceeds of $30,000,000 to occur concurrently with the consummation of our Business Combination, 3,000,000 of our Units on substantially the same terms as the sale of Units in our public offering at $10.00 per Unit, and 750,000 shares of Class A common stock. In connection with the execution of the Transaction Agreement, on August 2, 2020, the Company and Sponsor entered into an Amendment to the forward purchase contract, pursuant to which, among other things, Sponsor agreed to purchase 3,500,000 shares of GCM PubCo (as defined below) Class A common stock and 1,500,000 GCM PubCo common warrants for an aggregate purchase price of $30,000,000.

The issuance of additional shares in connection with a Business Combination to the owners of the target or other investors:

Similarly, if we issue debt securities or otherwise incur significant debt to bank or other lenders or the owners of a target, it could result in:

As indicated in the accompanying unaudited condensed financial statements, as of September 30, ~~2019,~~2020, we had approximately ~~$168,000~~$270,600 outside the trust account in cash. We expect to incur significant costs in the pursuit of our Business Combination plans. We cannot provide assurance that our plans to complete our Business Combination will be successful.

On August 2, 2020, we entered into a Transaction Agreement regarding our initial Business Combination (the “Transaction Agreement”) with CF Finance Intermediate Acquisition, LLC, a Delaware limited liability company and direct wholly owned subsidiary of the Company, Sponsor, Grosvenor Holdings, LLC, an Illinois limited liability company, Grosvenor Capital Management Holdings, LLLP, an Illinois limited liability limited partnership (“Grosvenor Capital”), GCM Grosvenor Management, LLC, a Delaware limited liability company, Grosvenor Holdings II, L.L.C., a Delaware limited liability company, GCMH GP, L.L.C., a Delaware limited liability company, GCM V, LLC, a Delaware limited liability company, and GCM Grosvenor Inc., a Delaware corporation and a direct wholly owned subsidiary of Grosvenor Capital (“GCM PubCo”). Pursuant to the Transaction Agreement, the Company will be merged (the “Merger”) with and into GCM PubCo, with GCM PubCo surviving the Merger, as a result of which GCM PubCo, as the surviving corporation in the Merger, will indirectly hold approximately 26.1% of the outstanding equity interests of Grosvenor Capital, assuming that no shares of the Company’s common stock are redeemed in connection with the Merger. The shares of Class A common stock will automatically convert into shares of GCM Pubco Class A common stock in connection with the Merger.For more information about the business combination, see the definitive proxy statement/prospectus dated October 14, 2020 and filed with the SEC on October 15, 2020.

In connection with the execution of the Transaction Agreement, on August 2, 2020, the Company and the Sponsor entered into Amendment No. 1 to Forward Purchase Contract, pursuant to which, among other things, the Sponsor agreed to purchase, subject to the Company’s consummation of a Business Combination with GCM PubCo and its affiliates, to a reduction in the total equity issuable under such contract to a total of 3,500,000 shares of GCM PubCo Class A common stock and 1,500,000 GCM PubCo common warrants, for the same $30,000,000 in gross proceeds.

~~For the period from July 9, 2014 (inception) through September 30, 2019, our activities consisted of formation and preparation for the Public Offering and subsequent to~~Since the Public Offering, our ~~efforts~~activities have ~~been~~consisted of efforts directed towards locating a suitable target and completing a suitable Business Combination. Our operating costs for those periods include our search for a Business Combination and are largely associated with expenses related to being a public company ~~incurred for~~(for legal, IR, accounting, auditing compliance and other ~~purposes,~~purposes) as well as expenses as we conduct due diligence on prospective Business Combination candidates.

In order to finance transaction costs in connection with an intended Business Combination, our sponsor has committed $750,000 to be provided to us to fund our expenses relating to investigating and selecting a target business and other working capital requirements. In addition, our sponsor or an affiliate of our sponsor or certain of our officers and directors may, but are not obligated to, loan us additional funds as may be required. In the event that our Business Combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our trust account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into warrants, at a price of $1.00 per warrant at the option of the lender. The warrants would be identical to the warrants included in the Private Placement Units, including as to exercise price, exercisability and exercise period. The terms of such additional loans, if any, have not been determined and no written agreements exist with respect to such loans. We do not expect to seek loans from parties other than our sponsor or an affiliate of our sponsor, or our directors or officers, as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account.

On December 17, 2018, we closed the Public Offering for the sale of 25,000,000 Units at a price of $10.00 per Unit, yielding gross proceeds of $250,000,000. Simultaneous with the closing of the Public Offering on December 17, 2018, we consummated the sale of 600,000 Private Placement Units at a price of $10.00 per Unit ($6,000,000 in the aggregate) in the Private Placement. On December 31, 2018, the underwriter partially exercised 2,500,000 Units of the over-allotment ~~option.~~option generating additional gross proceeds of $25,000,000. On January 29, 2019, the underwriter partially exercised the over-allotment option and purchased an additional 758,413 Units at an offering price of $10.00 per Unit, generating additional gross proceeds of $7,584,130. Upon the December 17, 2018, ~~and~~ December 31, 2018 and January 29, 2019 closings of the Public Offering, and June 15, 2020 Business Combination extension approval the sponsor funded loans in the amount of $2,500,000, $250,000, $75,841 and ~~$250,000,~~$2,489,824, respectively, pursuant to a promissory ~~note~~notes issued by the Company. The promissory ~~note is~~notes are interest free. The proceeds of the sponsor loans were deposited into the trust account and will be used to fund the redemption of the public shares (the “Public Shares”) (subject to the requirements of applicable law). Upon the closing of the Public Offering and the sale of the Private Placement Units, in December 2018 and January 2019, an aggregate of approximately ~~$278,000,000~~$286,000,000 (approximately $211,500,000 after the redemption on June 15, 2020 and September 10, 2020) was deposited in the trust account. On January 29, 2019, the underwriter partially exercised the over-allotment option and purchased an additional 758,413 Units at an offering price of $10.00 per Unit, generating additional gross proceeds of $7,584,130 and the Company borrowed an additional $75,841 under the promissory note with the Company's sponsor, which was deposited into the trust account. Since the over-allotment option was not exercised in full, simultaneously with the exercise of the second partial exercise of the over-allotment option, our sponsor forfeited 122,897 shares of our Class B common stock.

The net proceeds from the Public Offering ~~the over-allotment,~~ and Private Placement ofwas approximately $286,000,000 (approximately $211,500,000 after the redemptions on June 15, 2020 and September 10, 2020), net of the underwriting commissions of $5,100,000 and offering costs and other expenses of approximately ~~$485,900,~~$485,900. Such proceeds have been deposited in the trust account and are not available to us for operations (except amounts to pay taxes). As of September 30, ~~2019,~~2020, we had approximately ~~$168,000~~$270,600 of cash available outside of the trust account to fund our activities until we consummate a Business Combination.

Until the consummation of the Public Offering, the Company’s only sources of liquidity were a capital contribution from our sponsor of $50,383 for the founder shares (Class B common stock) and up to $300,000 in loans made available from the sponsor under an unsecured promissory note.

The Company believes that it has sufficient working capital as of September 30, ~~2019~~2020 to fund its operations through at least December ~~2019.~~17, 2020, its mandatory liquidation date.

We have no obligations, assets or liabilities which would be considered off-balance sheet arrangements. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements.

We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or entered into any agreements for non-financial assets.

As of September 30, ~~2019,~~2020, we did not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities.

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. The Company has identified the following as its critical accounting polices:

Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.

Net income (loss) per common share is computed by dividing net income (loss) applicable to common stockholders by the weighted average number of common shares outstanding during the period (after deducting shares that are subject to forfeiture in connection with the Public Offering), plus to the extent dilutive the incremental number of shares of common stock to settle warrants, as calculated using the treasury stock method. Shares of common stock subject to possible redemption as of September 30, ~~2019~~2020 have been excluded from the calculation of basic income (loss) per share for the period from July 9, 2014 (date of inception) to September 30, ~~2019~~2020 since such shares, if redeemed, only participate in their pro rata share of the trust account. For the period from July 9, 2014 (date of inception) to September 30, ~~2019,~~2020, the fully diluted calculation adds back the shares subject to redemption.

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, ~~“Fair~~Fair Value Measurements and ~~Disclosures,”~~Disclosures, approximates the carrying amounts represented in the accompanying balance sheet.

The Company complies with the requirements of the FASB ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (SAB) Topic ~~5A- “Expenses~~5A - Expenses of ~~Offering”~~Offering. Public Offering costs of approximately $5,585,900 consist of underwriter’s discounts of approximately $5,100,000 and approximately $485,900 of professional, printing, filing, regulatory and other costs associated with the Public Offering were charged to additional paid in capital upon completion of the Public Offering.

The Company ~~follows the asset and liability method of accounting for~~files income ~~taxes under FASB ASC, 740, “Income Taxes.” Deferred~~ tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable incomereturns in the ~~years~~U.S. federal jurisdiction and various state and local jurisdictions. The Company is currently not under examination by tax authorities and is not aware of any issues that may result in ~~which those temporary differences are expected to be recovered~~significant payments or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. As of September 30, 2019 the Company had no material deferred tax assets.accruals.

All of the approximately 28,260,000 shares of common stock sold as part of the Units in the Public Offering contain a redemption feature which allows for the redemption of such common stock under the Company’s liquidation or tender offer/stockholder approval provisions. In accordance with ASC 480, redemption provisions not solely within the control of the Company require the security to be classified outside of permanent equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of ASC 480. Although the Company does not specify a maximum redemption threshold, its amended and restated certificate of incorporation provides that in no event will the Company redeem its Public Shares in an amount that would cause its net tangible assets (stockholders’ equity) to be less than $5,000,001.

On June 15, 2020 and September 10, 2020, 593,700 and 6,592,942 shares of common stock were redeemed by public shareholders in connection with the extension of the Combination Period, respectively.

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the security to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock are affected by charges against additional paid-in capital.

As of September 30, 2020 and December 31, 2019, ~~27,908,863~~20,371,594 and 27,972,537 shares, respectively, of the approximately 21,070,000 and 28,260,000 Public Shares, respectively, were classified outside of permanent equity at redemption value of $10.19 and $10.10 per ~~share.~~share, respectively.

Management does not believe that there are any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

~~As of September 30, 2019, we were not subject to any market or interest rate risk. Following the consummation of the Public Offering, the~~The net proceeds of our initial public offering and the ~~Public Offering and Private Placement, including amounts~~sale of the private units held in the trust account ~~have been~~are invested in U.S. government treasury bills ~~notes or bonds~~ with a maturity of 180 days or less or in ~~certain~~ money market funds ~~that~~meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest ~~solely~~only in ~~US treasuries.~~direct U.S. government treasury obligations. Due to the short-term nature of these investments, we believe there will be no associated material exposure to interest rate risk.

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, ~~2019.~~2020. Based upon their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15 (e) and 15d-15 (e) under the Exchange Act) were effective.

During the most recently completed fiscal quarter, there has been no change in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

~~None.~~To the knowledge of our management, there is no litigation currently pending against us, any of our officers or directors in their capacity as such or against any of our property.

Factors that could cause our actual results to differ materially from those in this Quarterly Report are any of the risks described in our Annual Report on Form 10-K for the period ended December 31, ~~2018~~2019 (the “Form 10-K”)., as supplemented by our Quarterly Report on Form 10-Q for the period on March 31, 2020 and the definitive proxy statement filed with the SEC on October 15, 2020. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in the Form 10-K, except we may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.

On December 17, 2018, we consummated the Public Offering of 25,000,000 units, each unit consisting of one share of Class A common stock and three-quarters of one warrant. The units were sold at an offering price of $10.00 per unit, generating total gross proceeds of $250,000,000. The securities sold in the offering were registered under the Securities Act of 1933, as amended (“Securities Act”) on a registration statement on Form S-1 (No. 333-228420). The SEC declared the registration statement effective on December 12, 2018.None.

Simultaneously with the consummation of the Public Offering, we consummated the Private Placement of 600,000 Private Placement Units to our sponsor at a price of $10.00 per Private Placement Unit, generating total proceeds of $6,000,000. Such securities were issued pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act. In addition, simultaneously with the consummation of the Public Offering, pursuant to a promissory note we issued to our sponsor, our sponsor loaned us $2,500,000.

On December 31, 2018, the underwriters partially exercised the over-allotment option and purchased 2,500,000 units, generating gross proceeds of $25,000,000. In addition, on January 29, 2019, the underwriters partially exercised the over-allotment option and purchased 758,413 units, generating gross proceeds of $7,584,130.

Simultaneously with the consummation of the initial exercise of the underwriters’ over-allotment option on December 31, 2018, our sponsor loaned us an additional $250,000 and simultaneously with the consummation of the second exercise of the underwriters’ over-allotment option on January 29, 2019, our sponsor loaned us an additional $75,841.

The Private Placement Units are the same as the units sold in the Public Offering, except that warrants included in the Private Placement Units (the “Private Placement Warrants”) are not transferable, assignable or salable until after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants are exercisable on a cashless basis, are non-redeemable so long as they are held by the initial purchasers or their permitted transferees and will not be exercisable more than five years from the effective date of our registration statement, or December 12, 2023, in accordance with FINRA Rule 5110(f)(2)(G)(i).

~~Of the gross proceeds received from the Public Offering and the Private Placement, $285,409,971 was placed in the Trust Account.~~

We paid a total of $5,100,000 in underwriting discounts and commissions, including qualified independent underwriter fee, and approximately $485,900 for other costs and expenses related to the Public Offering. In addition, we have engaged Cantor Fitzgerald & Co. (“CF&Co”) as an advisor in connection with our business combination, pursuant to a Business Combination Marketing Agreement. We will pay CF&Co a cash fee for such services upon the consummation of our initial business combination in an amount equal to $9,890,445, which is equal to 3.5% of the gross proceeds of the Public Offering, including any proceeds from the partial exercises of the underwriters’ over-allotment option.

~~For a description of the use of the proceeds generated in the Public Offering, see Part I, Item 2 of this Form 10-Q.~~

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

Pursuant to the requirements of Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Units, each consisting of one share of Class A common stock and three-quarters of one redeemable warrant	CFFAU	The Nasdaq Capital Market
Class A common stock, par value $0.0001 per share	CFFA	The Nasdaq Capital Market
Redeemable warrants, exercisable for Class A common stock at an exercise price of $11.50 per share	CFFAW	The Nasdaq Capital Market

☐	Large accelerated filer	☐☒	Accelerated filer
☒☐	Non-accelerated filer	☒	Smaller reporting company
		☒	Emerging growth company

		Page

PART 1 – FINANCIAL INFORMATION

Item 1.	Financial Statements

	Condensed Balance Sheets as of September 30, ~~2019~~2020 (unaudited) and December 31, ~~2018~~2019	F-1
	Condensed Statements of Operations for the Three and Nine Months Ended September 30, 2020 and 2019 ~~and 2018~~ (unaudited)	F-2
	Condensed Statements of Changes in Stockholders’ Equity for the Three and Nine Months Ended September 30, 2020 and 2019 ~~and 2018~~ (unaudited)	F-3
	Condensed Statements of Cash Flows for the Nine Months Ended September 30, 2020 and 2019 ~~and 2018~~ (unaudited)	F-4
	Notes to Condensed Financial Statements (unaudited)	F-5

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	3

Item 3.	Quantitative and Qualitative Disclosures about Market Risk	7

Item 4.	Controls and Procedures	7

PART II – OTHER INFORMATION		8

~~Item 1.~~	~~Legal Proceedings~~	8

~~Item 1A.~~	~~Risk Factors~~	8

~~Item 2.~~	~~Unregistered Sales of Equity Securities and Use of Proceeds~~	8

~~Item 3.~~	~~Defaults Upon Senior Securities~~	9

Item 4.1.	~~Mine Safety Disclosures~~Legal Proceedings	9

Item 5.1A.	~~Other Information~~Risk Factors	9

Item 6.2.	Unregistered Sales of Equity Securities and Use of Proceeds	9

Item 3.	Defaults Upon Senior Securities	9

Item 4.	Mine Safety Disclosures	9

Item 5.	Other Information	9

Item 6.	Exhibits	10

SIGNATURES		11

No.		Description of Exhibit
31.1*		Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*		Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1**		Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2**		Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*		Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because iXBRL tags are embedded within the Inline XBRL document
101.CAL*		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.SCH*		Inline XBRL Taxonomy Extension Schema Document
101.DEF*		Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*		Inline XBRL Taxonomy Extension Labels Linkbase Document
101.PRE*		Inline XBRL Taxonomy Extension Presentation Linkbase Document
104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

	CF FINANCE ACQUISTION CORP.

Date: ~~November 14, 2019~~October 30, 2020		/s/ Howard W. Lutnick
	Name:	Howard W. Lutnick
	Title:	Chairman and Chief Executive Officer
		(Principal Executive Officer)

Date: ~~November 14, 2019~~October 30, 2020		/s/ ~~Steven Bisgay~~Paul Pion
	Name:	~~Steven Bisgay~~Paul Pion
	Title:	Chief Financial Officer ~~and Director~~
		(Principal Financial and Accounting Officer)

	September 30, 2019
Description	Carrying Value		Gross Unrealized Holding Gains		Quoted prices in Active Markets (Level 1)
Assets:
Money market fund	$	261,516	$	—	$	261,516
U.S. government treasury bills		290,304,935		27,263		290,332,198
Total	$	290,566,451	$	27,263	$	290,593,714

	December 31, 2018
Description	Carrying Value		Gross Unrealized Holding Losses			Quoted prices in Active Markets (Level 1)
Assets:
Cash	$	25,251,806	$	—		$	25,251,806
U.S. government treasury bills		252,721,203		(30,458	)		252,690,745
Total	$	277,973,009	$	(30,458	)	$	277,942,551

	Assets at Fair Value at September 30, 2020
Description	Level 1		Level 2		Level 3		Total
Cash and investments held in Trust Account
Money market fund	$	218,717,961	$	—	$	—	$	218,717,961
Total	$	218,717,961	$	—	$	—	$	218,717,961

	Assets at Fair Value at December 31, 2019
Description	Level 1		Level 2		Level 3		Total
Cash and investments held in Trust Account
Money market fund	$	291,761,159	$	—	$	—	$	291,761,159
Total	$	291,761,159	$	—	$	—	$	291,761,159